Advances in aromatase inhibition: clinical efficacy and tolerability in the treatment of breast cancer.
Affiliation
Department of Breast Medical Oncology, M. D., Anderson Cancer Center, University of Texas, Houston, 77030, USA.Issue Date
2001-09
Metadata
Show full item recordCitation
Advances in aromatase inhibition: clinical efficacy and tolerability in the treatment of breast cancer. 2001, 7 (9):2620-35 Clin. Cancer Res.Journal
Clinical Cancer ResearchPubMed ID
11555572Type
ArticleLanguage
enISSN
1078-0432Collections
Related articles
- Steroidal aromatase inhibitors in elderly patients.
- Authors: Bajetta E, Zilembo N, Bichisao E, Pozzi P, Toffolatti L
- Issue date: 2000 Feb
- Double-blind randomised trial comparing the non-steroidal aromatase inhibitors letrozole and fadrozole in postmenopausal women with advanced breast cancer.
- Authors: Tominaga T, Adachi I, Sasaki Y, Tabei T, Ikeda T, Takatsuka Y, Toi M, Suwa T, Ohashi Y
- Issue date: 2003 Jan
- [Aromatase inhibitors: a review of clinical trials].
- Authors: Kerbrat P, Lefeuvre C
- Issue date: 2000 Dec
- [Preclinical evaluation of aromatase inhibitors antitumor activity].
- Authors: Auvray P, Bichat F, Genne P
- Issue date: 2000 Dec
- Aromatase inhibitors: past, present and future in breast cancer therapy.
- Authors: Dutta U, Pant K
- Issue date: 2008